A number of diseases can exhibit similarities to MS, both relapsingremitting or primary progressive, often to the point of misdiagnosis even by specialists (Table 1)
reconstitute immediately before use for optimal integrity Analytical Verification Each peptide undergoes full analytical characterization to confirm identity, purity, and structural fidelity: HPLC Chromatography Confirms purity and retention profiles Mass Spectrometry Verifies molecular mass and sequence identity Peptide Mapping Confirms correct sequence alignment for each component Amino Acid Analysis Validates expected residue composition Endotoxin Testing Ensures researchgrade specifications Analytical documentation is provided for every lot to support reproducibility and experimental reliability
Moderate caloric restriction (15-20% below maintenance) supports AOD-9604 protocols without triggering metabolic adaptation or excessive muscle loss
2.4 Sample preparation For LCQTOF-MS/MS analysis, 1 mg of powder or homogenized tablet was dissolved or extracted using 5 mL of a 1:1:1 (v/v/v) mixture of water/methanol/acetonitrile, assisted by ultrasonication for 10 min, and afterwards filtered by a Whatman 0.2 m pore size polytetrafluoroethylene (PTFE) filter medium (GE Healthcare, Chicago, IL, United States)
choline, which distributes cholesterol and prevents it from getting deposited in one part of the body